Related Experiment Video
Updated: May 3, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Higher remnant cholesterol is associated with an increased risk of amnestic mild cognitive impairment: a
Yating Ai1,2,3, Chunyi Zhou1, Ming Wang4
1School of Nursing, Hubei University of Chinese Medicine, Wuhan, China.
Background And Aims:
Amnestic mild cognitive impairment (aMCI) is the most common subtype of MCI, which carries a significantly high risk of transitioning to Alzheimer's disease. Recently, increasing attention has been given to remnant cholesterol (RC), a non-traditional and previously overlooked risk factor. The aim of this study was to explore the association between plasma RC levels and aMCI.
Methods:
Data were obtained from Brain Health Cognitive Management Team in Wuhan (https://hbtcm.66nao.com/admin/). A total of 1,007 community-dwelling elders were recruited for this project. Based on ten tools including general demographic data, cognitive screening and some exclusion scales, these participants were divided into the aMCI (n = 401) and normal cognitive groups (n = 606). Physical examinations were conducted on all participants, with clinical indicators such as blood pressure, blood sugar, and blood lipids collected.
Results:
The aMCI group had significantly higher RC levels compared to the normal cognitive group (0.64 ± 0.431 vs. 0.52 ± 0.447 mmol/L, p < 0.05). Binary logistics regression revealed that occupation (P<0.001, OR = 0.533, 95%CI: 0.423-0.673) and RC (p = 0.014, OR = 1.477, 95% CI:1.081-2.018) were associated factors for aMCI. Partial correlation analysis, after controlling for occupation, showed a significant negative correlation between RC levels and MoCA scores (r = 0.059, p = 0.046), as well as Naming scores (r = 0.070, p = 0.026). ROC curve analysis demonstrated that RC levels had an independent predictive efficacy in predicting aMCI (AUC = 0.580, 95%CI: 0.544 ~ 0.615, P < 0.001).
Conclusion:
Higher RC levels were identified as an independent indicator for aMCI, particularly in the naming cognitive domain among older individuals. Further longitudinal studies are necessary to validate the predictive efficacy of RC.
Insights
Higher remnant cholesterol (RC) levels are linked to amnestic mild cognitive impairment (aMCI) in older adults. This study suggests RC may be an independent indicator for aMCI, especially affecting naming abilities.
Area of Science:
- Neuroscience
- Cardiovascular Research
- Gerontology
Background:
- Amnestic mild cognitive impairment (aMCI) is a common precursor to Alzheimer's disease.
- Remnant cholesterol (RC) is an emerging, overlooked risk factor for cognitive decline.
Purpose of the Study:
- To investigate the association between plasma remnant cholesterol (RC) levels and amnestic mild cognitive impairment (aMCI).
Main Methods:
- A total of 1,007 community-dwelling elders were recruited and categorized into aMCI (n=401) and normal cognitive groups (n=606).
- Data collected included demographic information, cognitive screening, physical examinations, and blood lipid profiles.
- Statistical analyses included binary logistic regression, partial correlation, and ROC curve analysis.
Main Results:
- Individuals with aMCI exhibited significantly higher plasma RC levels compared to the normal cognitive group (p < 0.05).
- RC levels were identified as an independent associated factor for aMCI (OR=1.477, p=0.014).
- Higher RC levels correlated negatively with MoCA and Naming scores, and demonstrated independent predictive efficacy for aMCI (AUC=0.580, p < 0.001).
Conclusions:
- Elevated plasma RC levels are an independent indicator for aMCI in older adults.
- The association appears particularly relevant to the naming cognitive domain.
- Further longitudinal research is warranted to confirm the predictive value of RC for aMCI.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Alzheimer Disease l: Introduction
Dementia l: Introduction